Sopracordevole Francesco, Mancioli Francesca, Clemente Nicolò, De Piero Giovanni, Buttignol Monica, Giorda Giorgio, Ciavattini Andrea
From the Gynecological Oncology Unit, Centro di Riferimento Oncologico - National Cancer Institute (FS, GDP, MB, GG); and Woman's Health Sciences Department, Gynecologic Section, Polytechnic University of Marche, Ancona, Italy (FM, NC, AC).
Medicine (Baltimore). 2015 Oct;94(42):e1827. doi: 10.1097/MD.0000000000001827.
The aim of this study was to analyze the correlation between the first diagnosis of high-grade Vaginal Intraepithelial Neoplasia (HG-VaIN: VaIN 2-VaIN 3) and the cytological abnormalities on the referral pap smear.All the women with histological diagnosis of HG-VaIN consecutively referred to the Gynecological Oncology Unit of the Aviano National Cancer Institute (Aviano, Italy) from January 1991 to April 2014 and with a pap smear performed in the 3 months before the diagnosis were considered, and an observational cohort study was performed.A total of 87 women with diagnosis of HG-VaIN were identified. Major cytological abnormalities (HSIL and ASC-H) on the referral pap smear were significantly more frequent than lesser abnormalities (ASC-US and LSIL) in postmenopausal women (64.9% vs 36.7%, P = 0.02) and in women with a previous diagnosis of HPV-related cervical preinvasive or invasive lesions (70.5% vs 39.5%, P = 0.01). Diagnosis of VaIN 3 was preceded by major cytological abnormalities in most of the cases (72.7% vs 27.3%, P < 0.001).The diagnosis of HG-VaIN can be preceded by different abnormalities on referral pap smear. Major abnormalities are usually reported in postmenopausal women and in women with previous cervical HPV-related disease. However, ASC-US or LSIL do not exclude HG-VaIN, especially VaIN2. An accurate examination of the whole vaginal walls (or vaginal vault) must be performed in all the women who underwent colposcopy for an abnormal pap smear, and a biopsy of all suspicious areas is mandatory.
本研究旨在分析高级别阴道上皮内瘤变(HG-VaIN:VaIN 2-VaIN 3)的初次诊断与转诊时巴氏涂片细胞学异常之间的相关性。纳入1991年1月至2014年4月期间连续转诊至意大利阿维亚诺国家癌症研究所妇科肿瘤科且诊断为HG-VaIN、诊断前3个月内进行过巴氏涂片检查的所有女性,进行一项观察性队列研究。共确定87例诊断为HG-VaIN的女性。绝经后女性(64.9%对36.7%,P = 0.02)以及既往诊断为HPV相关宫颈上皮内瘤变或浸润性病变的女性(70.5%对39.5%,P = 0.01)转诊时巴氏涂片的主要细胞学异常(HSIL和ASC-H)明显比轻微异常(ASC-US和LSIL)更常见。在大多数病例中,VaIN 3的诊断之前存在主要细胞学异常(72.7%对27.3%,P < 0.001)。HG-VaIN的诊断之前转诊时巴氏涂片可能出现不同异常。主要异常通常见于绝经后女性以及既往有宫颈HPV相关疾病的女性。然而,ASC-US或LSIL不能排除HG-VaIN,尤其是VaIN2。对于所有因巴氏涂片异常而接受阴道镜检查的女性,必须对整个阴道壁(或阴道穹窿)进行准确检查,对所有可疑区域进行活检是强制性的。